Role of synaptic and nonsynaptic glutamate receptors in ischaemia induced neurotoxicity

Brain Research Bulletin

Volumn 112, Issue , 2015, Pages 1-6

  Brassai, A ^a   Suvanjeiev, R G ^a   Bán, E Gy ^a   Lakatos, M ^b  

^a UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

^b INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

Author keywords

Catecholamine; Glutamate; Ischaemia; Mechanism; Stroke

Indexed keywords

ADENOSINE TRIPHOSPHATE; CALCIUM ION; GLUCOSE; GLUTAMATE RECEPTOR; GLUTAMIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 2A; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 2B; OXYGEN; PURINERGIC RECEPTOR; SYNAPSE RECEPTOR;

APOPTOSIS; BRAIN HYPOXIA; BRAIN ISCHEMIA; CALCIUM TRANSPORT; DISEASE SIMULATION; EXCITOTOXICITY; HYPOGLYCEMIA; MIDDLE CEREBRAL ARTERY OCCLUSION; NERVE CELL NECROSIS; NERVE DEGENERATION; NEUROPROTECTION; NEUROTOXICITY; NEUROTRANSMISSION; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; ANIMAL; CELL DEATH; HUMAN; ISCHEMIA; METABOLISM; NERVE CELL; PATHOPHYSIOLOGY; PHYSIOLOGY; SYNAPSE;

ANIMALS; CELL DEATH; HUMANS; ISCHEMIA; NEURONS; RECEPTORS, GLUTAMATE; SYNAPSES;

EID: 84920129372     PISSN: 03619230     EISSN: 18732747     Source Type: Journal    
DOI: 10.1016/j.brainresbull.2014.12.007     Document Type: Review

References (98)

1. Adam-Vizi V. Production of reactive oxygen species in brain mitochondria: contribution by electron transport chain and non-electron transport chain sources. Antioxid. Redox Signal. 2005, 7(9-10):1140-1149.
2. Andó R.D., Sperlágh B. The role of glutamate release mediated by extrasynaptic P2X7 receptors in animal models of neuropathic pain. Brain Res. Bull. 2013, 93:80-85.
3. Bederson J.B., Pitts L.H., Tsuji M., Nishimura M.C., Davis R.L., Bartkowski H. Rat middle cerebral artery occlusion: evaluation of the model and development of a neurologic examination. Stroke 1986, 17:472-476.
4. Benveniste H., Drejer J., et al. Elevation of the extracellular concentrations of glutamate and aspartate in rat hippocampus during transient cerebral ischemia monitored by intracerebral microdialysis. J. Neurochem. 1984, 43(5):1369-1374.
5. Blashko H. Amine oxidase and amine metabolism. Pharmacol. Rev. 1952, 4:415-453.
6. Burke W.J., Li S.W., Chung H.D., Ruggiero D.A., Kristal B.S., et al. Neurotoxicity of MAO metabolites of catecholamine neurotransmitters: role in neurodegenerative diseases. Neurotoxicology 2004, 25:101-115.
7. Casanova J.R., Nishimura M., Swann J.W. The effects of early-life seizures on hippocampal dendrite development and later-life learning and memory. Brain Res. Bull. 2014, 103:39-48.
8. Cavaliere F., Florenzano F., Amadio S., Fusco F.R., Viscomi M.T., D'Ambrosi N., Vacca F., Sancesario G., Bernardi G., Molinari M., Volonte C. Up-regulation of P2X2, P2X4 receptor and ischemic cell death: prevention by P2 antagonists. Neuroscience 2003, 120:85-98.
9. Cavaliere F., Amadio S., Sancesario G., Bernardi G., Volonte C. Synaptic P2X7 and oxygen/glucose deprivation in organotypic hippocampal cultures. J. Cereb. Blood Flow Metab. 2004, 24:392-398.
10. Choi D.W. Glutamate neurotoxicity and diseases of the nervous system. Neuron 1988, 1:623-634.
11. Chu S., Xiong W., Zhang D., Soylu H., Sun C., Albensi B.C., Parkinson F.E. Regulation of adenosine levels during cerebral ischemia. Acta Pharmacol. Sin. 2013, 34:60-66.
12. Coelho J.E., Rebola N., Fragata I., Ribeiro J.A., de Mendonca A., Cunha R.A. Hypoxia-induced desensitization and internalization of adenosine A1 receptors in the rat hippocampus. Neuroscience 2006, 138:1195-1203.
13. Cohen M.V., Baines C.P., Downey J.M. Ischemic preconditioning: from adenosine receptor to KATP channel. Annu. Rev. Physiol. 2000, 62:79-109.
14. Collo G., Neidhart S., Kawashima E., Kosco-Vilbois M., North R.A., Buell G. Tissue distribution of the P2X7 receptor. Neuropharmacology 1997, 36:1277-1283.
15. Corradetti R., Lo Conte G., Moroni F., Passani M.B., Pepeu G. Adenosine decreases aspartate and glutamate release from rat hippocampal slices. Eur. J. Pharmacol. 1984, 104:19-26.
16. Coyle J.T., Puttfarcken P. Oxidative stress, glutamate, and neurodegenerative disorders. Science 1993, 262:689-695.
17. Delfin G., Leary M., Perman S.M., O'Rourke D.M., Levine J.M., Abella B.S. Postarrest targeted temperature management immediately following craniotomy - A case report. Ther. Hypothermia Temp. Manage. 2013, 3:143-147.
18. Doolette D.J. Mechanism of adenosine accumulation in the hippocampal slice during energy deprivation. Neurochem. Int. 1997, 30:211-223.
19. Duguid I.C. Presynaptic NMDA receptors: are they dendritic receptors in disguise?. Brain Res. Bull. 2013, 93:4-9.
20. Dunwiddie T.V., Masino S.A. The role and regulation of adenosine in the central nervous system. Annu. Rev. Neurosci. 2001, 24:31-55.
21. Editorial Neuroprotection: the end of an era?. Lancet 2006, 368:1548.
22. El-Hayek Y.H., Wu C., Ye H., Wang J., Carlen P.L., Zhang L. Hippocampal excitability is increased in aged mice. Exp. Neurol. 2013, 247:710-719.
23. Fekete Ádám E., Vizi S., Kovács K.J., Lendvai B., Zelles T. Layer-specific differences in reactive oxygen species levels after oxygen-glucose deprivation in acute hippocampal slices. Free Radic. Biol. Med. 2008, 44:1010-1022.
24. Fellin T., Pozzan T., Carmignoto G. Purinergic receptors mediate two distinct glutamate release pathways in hippocampal astrocytes. J. Biol. Chem. 2006, 281:4274-4284.
25. Figiel I., Kaczmarek L. Cellular and molecular correlates of glutamate-evoked neuronal programmed cell death in the in vitro cultures of rat hippocampal dentate gyrus. Neurochem. Int. 1997, 31:229-240.
26. Franke H., Gunther A., Grosche J., Schmidt R., Rossner S., Reinhardt R., Faber-Zuschratter H., Schneider D., Illes P. P2X7 receptor expression after ischemia in the cerebral cortex of rats. J. Neuropathol. Exp. Neurol. 2004, 63:686-699.
27. Gendron F.P., Neary J.T., Theiss P.M., Sun G.Y., Gonzalez F.A., Weisman G.A. Mechanisms of P2X receptormediated ERK1/2 phosphorylation in human astrocytoma cells. Am. J. Physiol. Cell Physiol. 2003, 284:C571-C581.
28. +]-induced release of [H] noradrenaline in rat hippocampal slices. Neuroscience 2001, 104:761-768.
29. Gidday J.M. Cerebral preconditioning and ischaemic tolerance. Nat. Rev. Neurosci. 2006, 7:437-448.
30. Gogas K.R. Glutamate-based therapeutic approaches: NR2B receptor antagonists. Curr. Opin. Pharmacol. 2006, 6:68-74.
31. Goldberg M.P., Choi D.W. Combined oxygen and glucose deprivation in cortical cell culture: calcium-dependent and calcium-independent mechanisms of neuronal injury. J. Neurosci. 1993, 13(8):3510-3524.
32. Hardingham G.E., Fukunaga Y., et al. Extrasynaptic NMDARs oppose synaptic NMDARs by triggering CREB shutoff and cell death pathways. Nat. Neurosci. 2002, 5(5):405-414.
33. 2 in vitro. Brain Res. 1995, 671:181-186.
34. Khatun S., Chaube S.K., Bhattacharyya C.N. Generation of hydrogen peroxide mediates hanging death-induced neuronal cell apoptosis in the dentate gyrus of the rat brain. Brain Res. Bull. 2013, 95:54-60.
35. i in the dendrites and boutons of non-fast-spiking GABAergic hippocampal interneurons using two-photon laser microscopy and high- and low-affinity dyes. J. Physiol. 2013, 591:5541-5553.
36. Kiss J.P., Szasz B.K., et al. GluN2B-containing NMDA receptors as possible targets for the neuroprotective and antidepressant effects of fluoxetine. Neurochem. Int. 2012, 60(2):170-176.
37. Kopach O., Voitenko N. Extrasynaptic AMPA receptors in the dorsal horn: evidence and functional significance. Brain Res. Bull. 2013, 93:47-56.
38. Kristian T., Siesjo B.K. Calcium in ischemic cell death. Stroke 1998, 29:705-718.
39. Lee J.M., Zipfel G.J., Choi D.W. The changing landscape of ischaemic brain injury mechanisms. Nature 1999, 399:A7-A14.
40. Leker R.R., Shohami E. Cerebral ischemia and trauma: different etiologies yet similar mechanisms: neuroprotective opportunities. Brain Res. 2002, 39:55-73.
41. Lendvai B., Vizi E.S. Nonsynaptic chemical transmission through nicotinic acetylcholine receptors. Physiol. Rev. 2008, 88(2):333-349.
42. Lendvai B., Kassai F., Szájli A., Némethy Z. α7 nicotinic acetylcholine receptors and their role in cognition. Brain Res. Bull. 2013, 93:86-96.
43. Lipton P. Ischemic cell death in brain neurons. Physiol. Rev. 1999, 79:1431-1568.
44. Liu D.D., Yang Q. Brain Res. Bull. 2013, 93:10-16.
45. Liu H., Zhang J. Cerebral hypoperfusion and cgnitive impairment: the pathogenic role of vascular oxidative stress. Int. J. Neurosci. 2012, 122:494-499.
46. Liu S.B., Zhao M.G. Neuroprotective effect of estrogen: role of nonsynaptic NR2B-containing NMDA receptors. Brain Res. Bull. 2013, 93:27-31.
47. Liu Y., Wong T.P., Aarts M., Rooyakkers A., Liu L., Lai T.W., Wu D.C., Lu J., Tymianski M., Craig A.M., Wang Y.T. NMDA receptor subunits have differential roles in mediating excitotoxic neuronal death both in vitro and in vivo. J. Neurosci. 2007, 27:2846-2857.
48. Manji H.K., Quiroz J.A., Sporn J., Payne J.L., Denicoff K., Gray N., Chen G., Zarate C.A., Charney D.S., et al. Enhancing neuronal plasticity and cellular resilience to develop novel, improved therapeutics for difficult-totreat depression. Biol. Psychiatry 2003, 53(8):707-742.
49. Matsuoka Y., Kitamura Y., Fukunaga R., Shimohama S., Nabeshima T., Tooyama I., Kimura H., Taniguchi T. In vivo hypoxia-induced neuronal damage in dentate gyrus of rat hippocampus: changes in NMDA receptors and the effect of MK-801. Neurochem. Int. 1997, 30:533-542.
50. Maya Vetencourt J.F., Sale A., Viegi A., Baroncelli L., De Pasquale R., O'Leary O.F., Castren E., Maffei L., et al. The antidepressant fluoxetine restores plasticity in the adult visual cortex. Science 2008, 320(5874):385-388.
51. Milusheva E., Dóda M., Pasztor E., Lajtha S.H., Vizi E.S. Regulatory interactions among axon terminals affecting the release of different transmitters from rat striatal slices under hypoxic and hypoglycemic conditions. J. Neurochem. 1992, 59:946-952.
52. o-dependent and independent release of 83H8dopamine in rat striatal slices. Neurochem. Int. 1996, 28:501-507.
53. 2 upon chronic rotenone treatment. Free Radic. Biol. Med. 2005, 39:133-142.
54. Milusheva E.A., Baranyi M., Kormos E., Hracskó Z., Vizi E.S., Sperlágh B. The effect of antiparkinsonian drugs on oxidative stress induced pathological [3H]dopamine efflux after in vitro rotenone exposure in rat striatal slices. Neuropharmacology 2010, 58:816-825.
55. Monyer H., Burnashev N., Laurie D.J., Sakmann B., Seeburg P.H. Developmental and regional expression in the rat brain and functional properties of four NMDA receptors. Neuron 1994, 12:529-540.
56. Moro M.A., Almeida A., Bolaños J.P., Lizasoain I. Mitochondrial respiratory chain and free radical generation in stroke. Free Radic. Biol. Med. 2005, 39(10):1291-1304. Review. PubMed PMID: 16257638.
57. Musazzi L., Racagni G., Popoli M. Stress, glucocorticoids and glutamate release: effects of antidepressant drugs. Neurochem. Int. 2011, 59:138-149.
58. Nagy J., Horvath C., et al. NR2B subunit selective NMDA antagonists inhibit neurotoxic effect of alcohol-withdrawal in primary cultures of rat cortical neurones. Neurochem. Int. 2004, 44:17-23.
59. Nakai T., Milusheva E.A., Baranyi M., Uchihashi Y., Satoh T., Vizi E.S. Excessive release of noradrenaline and glutamate in response to stimulation of ischemic condition in rat spinal cord slice preparation: effect of NMDA and AMPA receptor antagonist. Eur. J. Pharmacol. 1999, 366:143-150.
60. Nishio N., Taniguchi W., Sugimura Y.K., Takiguchi N., Yamanaka M., Kiyoyuki Y., Yamada H., Miyazaki N., Yoshida M., Nakatsuka T. Reactive oxygen species enhance excitatory synaptic transmission in rat spinal dorsal horn neurons by activating TRPA1 and TRPV1 channels. Neuroscience 2013, 247:201-212.
61. North R.A. Molecular physiology of P2X receptors. Physiol. Rev. 2002, 82:1013-1067.
62. Pedata F., Latini S., Pugliese A.M., Pepeu G. Investigations into the adenosine outflow from hippocampal slices evoked by ischemia-like conditions. J. Neurochem. 1993, 61:284-289.
63. Perez E.L., Lauritzen F., et al. Evidence for astrocytes as a potential source of the glutamate excess in temporal lobe epilepsy. Neurobiol. Dis. 2012, 47(3):331-337.
64. Pérez-Pinzón M.A., Mumford P.L., Rosenthal M., Sick T.J. Anoxic preconditioning in hippocampal slices: role of adenosine. Neuroscience 1996, 75(3):687-694. PubMed PMID: 8951865.
65. Raveendran R., Devi Suma Priya S., Mayadevi M., Steephan M., Santhoshkumar T.R., Cheriyan J., Sanalkumar R., Pradeep K.K., James J., Omkumar R.V. Phosphorylation status of the NR2B subunit of NMDA receptor regulates its interaction with calcium/calmodulin-dependent protein kinase II. J. Neurochem. 2009, 110(1):92-105. PubMed PMID: 19453375. 10.1111/j.1471-4159.2009.06108.x.
66. Reynolds I.J., Hastings T.G. Glutamate induces the production of reactive oxygen species in cultured forebrain neurons following NMDA receptor activation. J. Neurosci. 1995, 15:3318-3327.
67. Rodrigues R.J., Almeida T., Richardson P.J., Oliveira C.R., Cunha R.A. Dual presynaptic control by ATP of glutamate release via facilitatory P2X1, P2X2/3, and P2X3 and inhibitory P2Y1, P2Y2, and/or P2Y4 receptors in the rat hippocampus. J. Neurosci. 2005, 25:6286-6295.
68. Rodriguez M., Sabate M., Rodriguez-Sabate C., Morales I. The role of non-synaptic extracellular glutamate. Brain Res. Bull. 2013, 93:17-26.
69. Rothman S. Synaptic release of excitatory amino acid neurotransmitter mediates anoxic neuronal death. J. Neurosci. 1984, 4:1884-1891.
70. Rudolphi K.A., Schubert P., Parkinson F.E., Fredholm B.B. Neuroprotective role of adenosine in cerebral ischaemia. Trends Pharmacol. Sci. 1992, 13:439-445.
71. Ryu J.K., Kim J., Choi S.H., Oh Y.J., Lee Y.B., Kim S.U., Jin B.K. ATP-induced in vivo neurotoxicity in the rat striatum via P2 receptors. Neuroreport 2002, 13:1611-1615.
72. Sakamoto A., Ohnishi S.T., Ohnishi T., Ogawa R. Relationship between free radical production and lipid peroxidation during ischemiareperfusion injury in the rat brain. Brain Res. 1991, 554:186-192.
73. Sánchez-Mendoza E., Bellver-Landete V., Merino J.J., González M.P., Martínez-Murillo R., Oset-Gasque M.J. Could neurotransmitters influence neurogenesis and neurorepair after stroke?. Neuropathol. Appl. Neurobiol. 2013, 39:722-735.
74. Sheldon A.L., Robinson M.B. The role of glutamate transporters in neurodegenerative diseases and potential opportunities for intervention. Neurochem. Int. 2007, 51:333-355.
75. Smith W.S. Pathophysiology of focal cerebral ischemia: a therapeutic perspective. J. Vasc. Interv. Radiol. 2004, 15:S3-S12.
76. Sperlágh B., Vizi E.S. The role of extracellular adenosine in chemical neurotransmission in the hippocampus and Basal Ganglia: pharmacological and clinical aspects. Curr. Top. Med. Chem. 2011, 11:1034-1046.
77. Sperlágh B., Kofalvi A., Deuchars J., Atkinson L., Milligan C.J., Buckley N.J., Vizi E.S. Involvement of P2X7 receptors in the regulation of neurotransmitter release in the rat hippocampus. J. Neurochem. 2002, 81:1196-1211.
78. Starkov A.A., Chinopoulos C., Fiskum G. Mitochondrial calcium and oxidative stress as mediators of ischemic brain injury. Cell Calcium 2004, 36:257-264.
79. Thomas C.G., Miller A.J., Westbrook G.L. Synaptic and extrasynaptic NMDA receptor NR2 subunits in cultured hippocampal neurons. J. Neurophysiol. 2006, 95:1727-1734.
80. Vanhoutte P., Bading H. Opposing roles of synaptic and extrasynaptic NMDA receptors in neuronal calcium signalling and BDNF gene regulation. Curr. Opin. Neurobiol. 2003, 13:366-371.
81. Vizi E.S. Presynaptic modulation of neurochemical transmission. Prog. Neurobiol. 1979, 12(3-4):181-290.
82. Vizi E.S. Role of high-affinity receptors and membrane transporters in nonsynaptic communication and drug action in the central nervous system. Pharmacol. Rev. 2000, 52(1):63-89.
83. Vizi E.S., Lábos E. Non-synaptic interactions at presynaptic level. Prog. Neurobiol. 1991, 37(2):145-163.
84. Vizi E.S., Lendvai B. Modulatory role of presynaptic nicotinic receptors in synaptic and non-synaptic chemical communication in the central nervous system. Brain Res. Rev. 1999, 30(3):219-235.
85. Vizi E.S., Fekete A., Karoly R., Mike A. Non-synaptic receptors and transporters involved in brain functions and targets of drug treatment. Br. J. Pharmacol. 2010, 160(4):785-809.
86. Vizi E.S., Kisfalvi M., Lorinczi T. Role of nonsynaptic GluN2B-containing NMDA receptors in excitotoxicity: evidence that fluoxetine selectively inhibits these receptors and may have neuroprotective effects. Brain Res. Bull. 2013, 93:32-38.
87. Wahl A.S., Buchthal B., et al. Hypoxic/ischemic conditions induce expression of the putative pro-death gene Clca1 via activation of extrasynaptic N-methyl-d-aspartate receptors. Neuroscience 2009, 158(1):344-352.
88. Wang C.P., Li J.L., Zhang L.Z., Zhang X.C., Yu S., Liang X.M., Ding F., Wang Z.W. Isoquercetin protects cortical neurons from oxygen-glucose deprivation-reperfusion induced injury via suppression of TLR4-NF-κB signal pathway. Neurochem. Int. 2013, 63:741-749.
89. Wang H.E., Wells J.M., Rizk D.V. Bullous lesions after use of a commercial therapeutic hypothermia temperature management system: a possible burn injury?. Ther. Hypothermia Temp. Manage. 2013, 3:147-150.
90. Wu L., Xu L., Xu X., Fan X., Xie Y., Yang L., Lan W., Zhu J., Xu G., Dai J., Jiang Y., Liu X. Keep warm and get success: the role of postsynaptic temperature in the mouse middle cerebral artery occlusion model. Brain Res. Bull. 2014, 101:12-17.
91. 2+ channels in hippocampal CA3 neurons of spontaneously epileptic rat (SER). Brain Res. Bull. 2013, 90:142-148.
92. Yuan H.B., Huang Y., Zheng S., Zuo Z. Hypothermic preconditioning increases survival of purkinje neurons in rat cerebellar slices after an in vitro simulated ischemia. Anesthesiology 2004, 100:331-337.
93. Yun J., Li J., Zuo Z. Transferred inter-cell ischemic preconditioning-induced neuroprotection may be mediated by adenosine A1 receptors. Brain Res. Bull. 2014, 103:66-71.
94. Zaugg M., Lucchinetti E., Spahn D.R., Pasch T., Schaub M.C. Volatile anesthetics mimic cardiac preconditioning by priming the activation of mitochondrial K(ATP) channels via multiple signaling pathways. Anesthesiology 2002, 97:4-14.
95. Zea Longa E.L., Weinstein P.R., Carlson S., Cummins R. Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke 1989, 20:84-91.
96. i increase in rat hippocampal CA1 pyramidal cells. Neurochem. Res. 2001, 26:1095-1100.
97. Zhong J., Russell S.L., Pritchett D.B., Molinoff P.B., Williams K. Expression of mRNAs encoding subunits of the N-methyl-d-aspartate receptor in cultured cortical neurons. Mol. Pharmacol. 1994, 45:846-853.
98. Zhou M., Baudry M. Developmental changes in NMDA neurotoxicity reflect developmental changes in subunit composition of NMDA receptors. J. Neurosci. 2006, 26:2956-2963.